Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Abstract Dysregulated insulin signaling in promoting α-synuclein aggregation and exacerbating the neuroinflammation process associated with Parkinson’s disease (PD). This study investigated whether 8-gingerol from ginger could protect against MPP⁺-induced α-synuclein aggregation and neuroinflammation in SH-SY5Y cells via the insulin signaling pathway. MTT assay showed that MPP⁺ markedly reduced SH-SY5Y cell viability at 0.5-2 mM. Treatment cells with 6-gingerol and 8-gingerol, but not 6-shogaol, significantly attenuated MPP⁺-induced cytotoxicity. The concentration at 20 μM showed the strongest neuroprotective effect. Immunoblots showed that 8-gingerol treatment attenuated the accumulation of Ser129p-α-synuclein and Thr23p-Tau induced by MPP⁺ for 24 h. Furthermore, 8-gingerol normalized the aberrant phosphorylation of IRS-1, Akt, and GSK-3β induced by MPP⁺. It also suppressed the MPP⁺-induced expression of inflammasome-associated proteins, such as FoxO1, TXNIP, NLRP3, and cleaved-caspase 1. Pre-treatment with the PI3K/Akt inhibitor wortmannin abrogated the protective effects by increased Ser129p-α-synuclein and NLRP3 inflammasome protein levels. These results indicated that 8-gingerol protects SH-SY5Y cells against MPP⁺-induced the α-synuclein aggregation and NLRP3 inflammasome activation is mediated through the insulin signaling pathway.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.